Table 1 The baseline characteristics of the IPF patients
Characteristics | Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 | Patient 6 | Patient 7 | Patient 8 | Patient 9 | Patient 10 | Patient 11 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Sex | M | F | M | F | M | M | M | F | M | M | M |
Age(years) | 66 | 57 | 67 | 63 | 64 | 72 | 67 | 40 | 70 | 62 | 49 |
BMI(Kg/m2) | 20.45 | 19.7 | 23.7 | 23.7 | 25.8 | 23.9 | 27.3 | 22.98 | 23.34 | 17.81 | 28.28 |
Smoking status | Current | Never | Former | Never | Former | Never | Current | Never | Never | Former | Current |
Antibiotic application | No | No | Yes | Yes | Yes | Yes | Yes | Yes | Yes | No | Yes |
Family history of IPF | Unknown | Yes | Unknown | Unknown | Unknown | Unknown | Unknown | Yes | Unknown | Unknown | No |
VC(%pro) | 45 | 38 | 71 | 68 | 77 | 72 | 54 | 33 | 58 | 65 | 48 |
FVC(L) | 1.39 | 1.01 | 1.98 | 1.46 | 2.84 | 2.17 | 1.85 | 1.07 | 1.92 | 3.07 | 1.90 |
FEV1 (L) | 1.35 | 0.95 | 1.98 | 1.30 | 2.24 | 1.81 | 1.55 | 1.00 | 1.72 | 2.99 | 1.68 |
FEV1/FVC(%) | 97.00 | 93.43 | 100.00 | 88.90 | 78.82 | 83.67 | 83.79 | 93.04 | 89.41 | 97.41 | 88.36 |
MEF25(% pro) | 57 | 47 | 229 | 52 | 45 | 60 | 45 | 43 | 107 | 179 | 49 |
MEF50(% pro) | 87 | 49 | 122 | 94 | 58 | 87 | 63 | 102 | 73 | 147 | 66 |
MEF75(%pro) | 151 | 58 | 88 | 99 | 90 | 106 | 107 | 91 | 57 | 107 | 65 |
TLC(L) | 3.02 | 3.11 | 3.77 | 2.38 | 4.64 | 3.66 | 3.08 | 2.05 | 3.93 | 5.74 | 3.16 |
RV (L) | 1.42 | 2.12 | 1.66 | 1.00 | 1.77 | 1.54 | 1.25 | 0.89 | 1.78 | 2.39 | 1.20 |
RV/TLC(%) | 47.00 | 68.13 | 44.02 | 41.79 | 38.28 | 42.06 | 40.72 | 43.56 | 45.39 | 41.67 | 38.18 |
MV (L/min) | 17.30 | 11.60 | 40.64 | 8.18 | 12.61 | 14.04 | 16.67 | 12.44 | 17.25 | 13.02 | 19.72 |
DLCO(%pro) | 45 | 38 | 23 | 47 | 23 | 61 | 26 | 24 | 34 | 23 | 49 |
Comorbidities | Hypertension | / | Hypertension; Diabetes | Liver disease | Coronary heart disease | / | Diabetes | Hyperlipemia | / | Hypertension Hyperlipemia | / |